
IBM Stock: Stable Dividend or Stagnant Investment?
The AI race has heated up significantly but returns on…
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
Income Statement | ||||||
Revenue | $5.5B | $7.4B | $8.6B | $2.1B | $2.3B | |
Gross Profit | $2.1B | $2.7B | $3.2B | $756M | $857M | |
Operating Income | $511M | $728M | $1.1B | $230M | $292M | |
EBITDA | $726M | $1.1B | $1.7B | $361M | $526M | |
Diluted EPS | $1.96 | $2.78 | $3.65 | $1.16 | $1.33 |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Balance Sheet | ||||||
Current Assets | $3.5B | $3.2B | $3B | $3.9B | $4.1B | |
Total Assets | $8.8B | $8.3B | $8B | $16.1B | $16.5B | |
Current Liabilities | $2B | $1.4B | $1.6B | $2.2B | $2.3B | |
Total Liabilities | $5.8B | $5.1B | $4.4B | $5.9B | $5.6B | |
Total Equity | $3B | $3.2B | $3.5B | $10.2B | $10.9B | |
Total Debt | $3.1B | $2.4B | $1.9B | $2.3B | $2B |
Trailing 12 Months | Fiscal Quarters | |||||
---|---|---|---|---|---|---|
Period Ending | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2023-12-31 | 2024-12-31 | |
Cash Flow Statement | ||||||
Cash Flow Operations | $596M | $837M | $1.3B | $455M | $575M | |
Cash From Investing | -$191M | -$628M | -$482M | -$89M | -$289M | |
Cash From Financing | -$790M | -$157M | -$615M | -$86M | -$95M | |
Free Cash Flow | $388M | $566M | $942M | $361M | $475M |
Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $8.6 billion in revenue in 2024.
In the current month, XYL has received 9 Buy ratings 7 Hold ratings, and 0 Sell ratings. The XYL average analyst price target in the past 3 months is $146.13.
According to analysts, the consensus estimate is that Xylem share price will rise to $146.13 per share over the next 12 months.
Analysts are divided on their view about Xylem share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Xylem is a Sell and believe this share price will drop from its current level to $114.15.
The price target for Xylem over the next 1-year time period is forecast to be $146.13 according to 16 Wall Street analysts, 9 of them rate the stock a Buy, 0 rate the stock a Sell, and 7 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for Xylem is a Buy. 9 of 16 analysts rate the stock a Buy at this time.
You can purchase shares of Xylem via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Xylem shares.
Xylem was last trading at $128.24 per share. This represents the most recent stock quote for Xylem. Yesterday, Xylem closed at $130.62 per share.
In order to purchase Xylem stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
The AI race has heated up significantly but returns on…
Trimble (NASDAQ:TRMB) is a hardware and software tech company that…
It seems like right now is a good time to…
Market Cap: $3.6T
P/E Ratio: 39x
Market Cap: $2.8T
P/E Ratio: 32x
Market Cap: $2.6T
P/E Ratio: 36x
Willdan Group [WLDN] is down 3.66% over the past day.
Pro-Dex [PDEX] is up 10.33% over the past day.
Samsara [IOT] is down 3.68% over the past day.